Tuesday, 18 February 2020

Japan News

  • Japanese firm suspends trial of ArQule candidate

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2012

    Singapore: Japanese pharmaceutical company Kyowa Hakko Kirin temporarily suspended patient enrollment in an international phase III clinical study evaluating the combination of ARQ 197 (tiv...Read more

  • Japan BIOtech 2013 concludes in huge success

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

    Singapore: "BIOtech 2013 in Japan", which recorded significant growth both in the scale and the quality, concluded in huge success. It witnessed 603 exhibitors from 25 countries (up from 49...Read more

  • Study shows Lipitor well-tolerated among Asians

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2012

    Singapore: A large-scale retrospective database analysis on atorvastatin (Lipitor) by Astellas Pharma and Pfizer Japan has demonstrated that atorvastatin is as well tolerated by the Asian p...Read more

  • Astellas to do interim analysis of cancer trial

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Apr, 2013

    Singapore: Medivation and Astellas Pharma have established an updated interim analysis plan for the Prevail trial, a global phase III clinical trial evaluating Xtandi (enzalutamide) capsule...Read more

  • Indian pharma to put up a grand show at Tokyo fair

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2014

    Singapore: The Indian Department of Commerce is showcasing the achievement of the country's pharmaceutical sector at the 'Brand India Pharma' show in the Tokyo fair. The three-day show, In...Read more

  • Japan to revise medical device approval procedures

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 13 Feb, 2013

    Singapore: In order to speed up the approval process for medical devices, Japan is planning to introduce some changes in the accreditation procedures. News reports emerging from Japan state...Read more

  • Another Japanese university finds data manipulation for Novartis drug

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: The Jikei University School of Medicine has become the second Japanese university to find that clinical data had been manipulated for a Novartis Pharma drug that lowers blood pre...Read more

  • Prism to start PRI-724 trials to treat fibrosis

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jun, 2013

    Singapore: Prism Pharma, a drug discovery company focused on developing small molecule technologies that modulate protein-protein interactions, announced the close of an approximately $15 m...Read more

  • Takeshi Yura is AMRI Asia discovery VP

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Feb, 2013

    Singapore: Dr Takeshi Yura has been promoted by AMRI to the position of vice president of discovery and development services, Asia. Dr Yura will report directly to Dr Thomas E. D'Ambra, cha...Read more

  • APAC stem cell therapy market to reach $972mn in 2018

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jan, 2013

    Singapore: A new study by Reports and Reports predicted that the stem cell therapy market in Asia Pacific (APAC) will grow in value from $545 million in 2012 to $972 million in 2018, at a c...Read more

  • Medtronic starts trial of renal denervation system in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Oct, 2012

    Singapore: Medtronic started Symplicity HTN-Japan, the first clinical trial with the Symplicity renal denervation system in Japan for patients with treatment-resistant hypertension. The cli...Read more

  • BMS-Pfizer stroke drug gets Japanese nod

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 27 Dec, 2012

    Singapore: Bristol-Myers Squibb and Pfizer announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved Eliquis (apixaban) for the prevention of ischemic stroke an...Read more

  • Chugai gets Japanese nod cancer drug Kadcyla

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 23 Sep, 2013

    Singapore: The Japanese Ministry of Health, Labour and Welfare has approved Oncology specializing pharmaceutical firm Chugai Pharmaceutical's anti-cancer agent Kadcyla, for HER2-positive in...Read more

  • Biosensors to collaborate with Terumo in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Feb, 2013

    Singapore: Biosensors International, a developer, manufacturer and marketer of innovative medical devices, is collaborating with Japanese company Terumo to promote the Nobori drug-eluting s...Read more

  • Nexavar seeks marketing authorization in Japan

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

    Singapore: Bayer HealthCare has submitted an additional application for marketing authorization to the Ministry of Health, Labour and Welfare (MHLW) in Japan for Nexavar (Sorafenib) tablets...Read more

  • Shinogi starts supply of Pirespa to Ildong

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 16 Oct, 2012

    Singapore: Osaka-based Shionogi has began to supply Pirespa 200mg tablet (pirfenidone) to Ildong Pharmaceutical, which is headquartered in Seoul, for the treatment of idiopathic pulmonary f...Read more

  • US-based TriReme looks for big growth in Asia

    Japan |  Influencers | By BioSpectrum Bureau  | 0 Comment | 31 May, 2012

    TriReme Medical, a US-based start-up medical devices company dedicated to the development and manufacturing of innovative devices for the treatment of complex vascular disease, recently ope...Read more

  • Abbott and Sucampo get nod for AMITIZA in Japan

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2012

    Singapore: Sucampo Pharma and Abbott received approval from the Ministry of Health, Labor and Welfare, Japan for AMITIZA (lubiprostone). The drug is a prescription medicine that is used for...Read more